- Home
- Publications
- Publication Search
- Publication Details
Title
Histone modifications: implications in renal cell carcinoma
Authors
Keywords
-
Journal
Epigenomics
Volume 5, Issue 4, Pages 453-462
Publisher
Future Medicine Ltd
Online
2013-07-29
DOI
10.2217/epi.13.40
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
- (2015) Cheryl M. Koh et al. Oncotarget
- KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
- (2013) W. L. Berry et al. CANCER RESEARCH
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
- (2013) C. Zagni et al. CURRENT MEDICINAL CHEMISTRY
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
- (2013) K.-M. Chan et al. GENES & DEVELOPMENT
- Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen
- (2013) Joyce Sayegh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
- (2013) Kristian W Pajtler et al. Acta Neuropathologica Communications
- The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
- (2012) Toshihiko Sakurai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression and significance of histone H3K27 demethylases in renal cell carcinoma
- (2012) Yongqing Shen et al. BMC CANCER
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Loss of PBRM1 expression is associated with renal cell carcinoma progression
- (2012) Rafal Pawłowski et al. INTERNATIONAL JOURNAL OF CANCER
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- New lysine methyltransferase drug targets in cancer
- (2012) Tobias Wagner et al. NATURE BIOTECHNOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates
- (2011) Silviya D. Furdas et al. ARCHIV DER PHARMAZIE
- Inhibitors of histone demethylases
- (2011) Brian Lohse et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically
- (2011) Akinori Sato et al. BJU INTERNATIONAL
- Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma
- (2011) Sebastian Rogenhofer et al. BJU INTERNATIONAL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- The Expression of Histone Demethylase JMJD1A in Renal Cell Carcinoma
- (2011) X. GUO et al. NEOPLASMA
- The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C
- (2011) X Niu et al. ONCOGENE
- Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
- (2011) Michele Cea et al. PLoS One
- Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
- (2010) Gerben Duns et al. CANCER RESEARCH
- Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma
- (2010) Davit Mosashvilli et al. CANCER SCIENCE
- SET7/9 mediated methylation of non-histone proteins in mammalian cells
- (2010) Sriharsa Pradhan et al. Epigenetics
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Epigallocatechin-3-Gallate, a Histone Acetyltransferase Inhibitor, Inhibits EBV-Induced B Lymphocyte Transformation via Suppression of RelA Acetylation
- (2009) K.-C. Choi et al. CANCER RESEARCH
- BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer
- (2009) S. Majid et al. CARCINOGENESIS
- Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels
- (2009) D. Mahalingam et al. CLINICAL CANCER RESEARCH
- Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells
- (2009) T.-L. Cha et al. CLINICAL CANCER RESEARCH
- Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 Enhances Hypoxic Gene Expression and Tumor Growth
- (2009) A. J. Krieg et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Erratum: Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
- (2009) E Lara et al. ONCOGENE
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
- (2008) W. Xia et al. CANCER RESEARCH
- Combination Strategy Targeting the Hypoxia Inducible Factor-1 with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors
- (2008) H. M.W. Verheul et al. CLINICAL CANCER RESEARCH
- The Sirtuin family: therapeutic targets to treat diseases of aging
- (2008) Jill C Milne et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Histone Acetyltransferase Inhibitor Anacardic Acid Causes Changes in Global Gene Expression during In VitroPlasmodium falciparumDevelopment
- (2008) Long Cui et al. EUKARYOTIC CELL
- The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
- (2008) Sophie Beyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix
- (2008) Jon Jones et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Histone Modifications and Nuclear Architecture: A Review
- (2008) Eva Bártová et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Decreased Acetylation of Histone H3 in Renal Cell Carcinoma: A Potential Target of Histone Deacetylase Inhibitors
- (2008) Kent Kanao et al. JOURNAL OF UROLOGY
- Chromatin, cancer and drug therapies
- (2008) Connie C. Cortez et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now